Clinical Consultation: Continuous Antibiotic Irrigation Through the IRRAflow Device for Central Nervous System Infections.

Bacterial central nervous system (CNS) infections carry high morbidity and mortality, and their management is complicated by limited antibiotic penetration across the blood brain barrier. The IRRAflow system is a dual-lumen ventricular catheter that enables continuous active cerebrospinal fluid exchange and has been used off-label for antibiotic delivery in refractory CNS infections. This clinical consultation reviews the available evidence, describes the device and its proposed rationale, and offers practical guidance for clinicians. Published experience is limited to case reports, case series, and small retrospective cohorts. In addition, there is no pharmacokinetic data available and clinical dosing is described for only two agents. The available evidence is insufficient to establish efficacy, define safe-use criteria, or support dosing strategies. Continuous antibiotic irrigation via IRRAflow cannot currently be recommended for routine use. Where it is used, it should be reserved for infections refractory to standard care, at experienced centers, with active clinical pharmacist involvement in agent selection, dosing, and monitoring, ideally within a prospective study.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-10-05
DOI
https://doi.org/10.1093/ajhp/zxag327
Primary Topic
Antibiotics Pharmacokinetics and Efficacy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Consultation: Continuous Antibiotic Irrigation Through the IRRAflow Device for Central Nervous System Infections.

Maria Gabriela Cabanilla, Matthew J. Briski, Joseph A. Iovine, Kevin A. Kaucher et al.
PubMed
Antibiotics Pharmacokinetics and Efficacy
article

Clinical Consultation: Continuous Antibiotic Irrigation Through the IRRAflow Device for Central Nervous System Infections.

Maria Gabriela Cabanilla, Matthew J. Briski, Joseph A. Iovine, Kevin A. Kaucher, Jacob Hurt
article en

Abstract

Bacterial central nervous system (CNS) infections carry high morbidity and mortality, and their management is complicated by limited antibiotic penetration across the blood brain barrier. The IRRAflow system is a dual-lumen ventricular catheter that enables continuous active cerebrospinal fluid exchange and has been used off-label for antibiotic delivery in refractory CNS infections. This clinical consultation reviews the available evidence, describes the device and its proposed rationale, and offers practical guidance for clinicians. Published experience is limited to case reports, case series, and small retrospective cohorts. In addition, there is no pharmacokinetic data available and clinical dosing is described for only two agents. The available evidence is insufficient to establish efficacy, define safe-use criteria, or support dosing strategies. Continuous antibiotic irrigation via IRRAflow cannot currently be recommended for routine use. Where it is used, it should be reserved for infections refractory to standard care, at experienced centers, with active clinical pharmacist involvement in agent selection, dosing, and monitoring, ideally within a prospective study.

PubMed
University of New Mexico Hospital (US), University of New Mexico (US), Seton Medical Center Austin (US), University of New Mexico Health Sciences Center (US)
Openalex Percentile: Top 12%
Antibiotics Pharmacokinetics and Efficacy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Consultation: Continuous Antibiotic Irrigation Through the IRRAflow Device for Central Nervous System Infections. — Maria Gabriela Cabanilla, Matthew J. Briski, et al. · PubMed (2026) | TGRS Research Map | TGRS